OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - GALA GROUNPV | Market Closed - Börse Stuttgart 12:01:17 31/05/2024 BST | ||
| 1.3 EUR | +19.27% |
|
| 1 month | +80.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
GALDERMA GROUP AG
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 1.3 | +19.27% |
| 30/05/24 | 1.09 | -6.03% |
| 29/05/24 | 1.16 | -12.12% |
| 28/05/24 | 1.32 | +10.00% |
| 27/05/24 | 1.2 | -9.77% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 12:01 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | GALDERMA GROUP AG |
| Issuer | 
Société Générale
|
| WKN | SW9EQ4 |
| ISIN | DE000SW9EQ40 |
| Date issued | 23/04/2024 |
| Strike | 60.88 CHF |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.56 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.37 € |
|---|---|
| Lowest since issue | 0.6 € |
Company Profile
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Sector
-
Consensus: Galderma Group AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
81.09
USD
Average target price
85.62
USD
Spread / Average Target
+5.59%
- Stock Market
- Certificates
- Certificat
